Relmada Therapeutics Stock Price Prediction

Intrinsic Valuation Low Real High 0.14 2.87 13.89 Details

3 Analysts Consensus Low Target High 9.45 10.38 11.52 Details

Earnings Estimates (0) Low Projected EPS High 0.00 0.00 0.00 Details

Relmada Therapeutics After-Hype Price Prediction Density Analysis

Relmada Therapeutics Estimiated After-Hype Price Volatility

Relmada Therapeutics Stock Price Prediction Analysis

Expected Return	Period Volatility	Hype Elasticity	Related Elasticity	News Density	Related Density	Expected Hype
2.01	11.02	0.06	0.05	7 Events / Month	7 Events / Month	In about 7 days

Latest traded price	Expected after-news price	Potential return on next major news	Average after-hype volatility
0.37	0.31	16.22	36,733   Notes

Relmada Therapeutics Hype Timeline

Relmada Therapeutics is at this time traded for 0.37. The entity has historical hype elasticity of -0.06, and average elasticity to hype of competition of 0.05. Relmada is expected to decline in value after the next headline, with the price expected to drop to 0.31. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -16.22%, whereas the daily expected return is at this time at -2.01%. The volatility of related hype on Relmada Therapeutics is about 47228.57%, with the expected price after the next announcement by competition of 0.42. About 46.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.23. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Relmada Therapeutics recorded a loss per share of 2.86. The entity last dividend was issued on the 30th of September 2019. The firm had 1:4 split on the 30th of September 2019. Given the investment horizon of 90 days the next expected press release will be in about 7 days. Check out Relmada Therapeutics Basic Forecasting Models to cross-verify your projections. For information on how to trade Relmada Stock refer to our How to Trade Relmada Stock guide.

Relmada Therapeutics Related Hype Analysis

Relmada Therapeutics Additional Predictive Modules

Most predictive techniques to examine Relmada price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Relmada using various technical indicators. When you analyze Relmada charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Relmada Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Relmada Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Relmada Therapeutics based on analysis of Relmada Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.

The number of cover stories for Relmada Therapeutics depends on current market conditions and Relmada Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Relmada Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Relmada Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Relmada Therapeutics' future price predictability will typically decrease when Relmada Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Relmada Therapeutics often depends not only on the future outlook of the potential Relmada Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Relmada Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.

When running Relmada Therapeutics' price analysis, check to measure Relmada Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relmada Therapeutics is operating at the current time. Most of Relmada Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relmada Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relmada Therapeutics' price. Additionally, you may evaluate how the addition of Relmada Therapeutics to your portfolios can decrease your overall portfolio volatility.